Investing.com - European stocks traded higher Wednesday, buoyed by increased optimism surrounding a December rate cut by the Federal Reserve ahead of the U.K.’s Autumn Budget. At 03:02 ET (08:02 GMT), ...

Read More »

FDA approves AstraZeneca’s Imfinzi for early-stage stomach and GEJ cancers

Investing.com -- AstraZeneca’s (LON:AZN) cancer drug Imfinzi (durvalumab) has been approved in the United States as a treatment for adults with certain types of stomach and gastroesophageal junction ...

Read More »

AstraZeneca's (LON:AZN) investors will be pleased with their respectable 55% return over the last five years

AstraZeneca PLC (LON:AZN) shareholders might be concerned after seeing the share price drop 11% in the last quarter. On the bright side the returns have been quite good over the last half decade.

Read More »

AstraZeneca CEO buys 20,000 company shares at £102.03 each

AstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN) disclosed today that Pascal Soriot, the Chief Executive Officer, has purchased 20,000 ordinary shares of the company for £102.03 per share. The transaction ...

Read More »

AstraZeneca Stock Hits All-Time High at $87.32 Amid Strong Growth

AstraZeneca PLC (LON: AZN) shares soared to an all-time high this week, reaching a peak of $87.32 USD. The pharmaceutical giant has seen its stock value climb significantly, marking a robust 1-year ...

Read More »